Hepatocellular Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Impact of Hepatectomy on HCC Recurrence
Conditions: Hepatocellular Carcinoma Stage I; Recurrence Interventions: Procedure: Major hepatectomy Sponsors: Anhui Medical University; National Natural Science Foundation of China Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Conditions: Hepatocellular Carcinoma; Radiotherapy; Pembrolizumab; Tumor Thrombosis Interventions: Radiation: Moderate-dose Hypofractionated Intensity-modulated Radiotherapy; Drug: Pembrolizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials

Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Conditions: Malignant Neoplasm of Liver Interventions: Drug: 68Ga-aGPC3-scFv/Fab Sponsors: Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials

Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular Interventions: Behavioral: ChatGPT; Behavioral: patient education with traditional methods. Sponsors: Taipei Veterans General Hospital, Taiwan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials

Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
Conditions: Hepatocellular Carcinoma Interventions: Diagnostic Test: ctDNA monitoring; Diagnostic Test: Plasma proteomic analysis Sponsors: Shanghai Zhongshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
Conditions: Hepatocellular Carcinoma; Hepatitis B Interventions: Diagnostic Test: Urine test Sponsors: Peking Union Medical College Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials

Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
Conditions: Hepatocellular Carcinoma Interventions: Radiation: Photon or proton radiotherapy Sponsors: Chang Gung Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma （uHCC）.
Conditions: Hepatocellular Carcinoma Non-resectable; Hepatocellular Carcinoma Interventions: Drug: Ivonescimab （AK112，a PD-1/VEGF bispecific antibody） Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials

HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure
Conditions: HCC - Hepatocellular Carcinoma Interventions: Drug: PD-L1 inhibitor: Adebrelimab Injection ；Regorafenib Tablets Sponsors: Yehua Shen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials

Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: AU409 capsules Sponsors: Lee ' s Pharmaceutical Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: HAIC+Serplulimab （HLX10）+ Bevacizumab Biosimilar（HLX04） Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Drug: AK104; Drug: Lenvatinib; Procedure: TACE; Other: Placebo for AK104; Other: Placebo for Lenvatinib Sponsors: Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma
Conditions: Lymphopenia Sponsors: Chang Gung Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

Liver Transplantation for Hepatocellular Carcinoma Arising in Non-cirrhotic Liver: a Propensity Score-matched Retrospective Cohort Study of Two National Databases
Conditions: Hepatocellular Carcinoma, Non-cirrhotic Liver Interventions: Other Sponsors: Xiao Xu Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Biological: γδ T cells; Drug: Targeted drugs; Drug: PD-1 monoclonal antibody Sponsors: Beijing 302 Hospital; Chinese Academy of Medical Sciences; Beijing GD Initiative Cell Therapy Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials